Demis Hassabis
-
Technology & Infrastructure · Models & LLMs Isomorphic Labs Founder Sees AI-Designed Drug Entering Trials by Year-End
Insider Brief Isomorphic Labs, an Alphabet-owned startup, plans to begin human trials for its first AI-designed drug by year-end, potentially revolutionizing the drug discovery process. The company, leveraging AI to accelerate drug development, has… -
Technology & Infrastructure · Models & LLMs AI Powers Pioneering Team’s Nobel Prize for Chemistry Win
-
Business & Markets · Enterprise Demis Hassabis on the Evolution & Challenges of AI
-
Business & Markets · Enterprise Tony Blair & Demis Hassabis Discuss the Opportunities of AI
-
Business & Markets · Enterprise “AI’s Overhyped in the Short Term and Probably Underestimated Over the Long Term”, Says Demis Hassabis
-
Business & Markets · Enterprise Can AI Unlock the Greatest Mysteries of Existence? Demis Hassabis Explores the Profound Potential
-
Business & Markets · Enterprise DeepMind’s Hassabis Warns AI Funding Surge May Lead to Excessive Hype
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.